Streetbeat News

Analyst Ratings

BAND

Citigroup analyst Tyler Radke maintains a Neutral rating on Bandwidth (NASDAQ:BAND) and raises the price target from $14 to $16.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 1:23 pm

CLS

RBC Capital has upgraded Celestica's stock from Sector Perform to Outperform and raised its price target from $14 to $22. This has resulted in Celestica shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 1:23 pm

EYPT

HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on EyePoint Pharmaceuticals (NASDAQ:EYPT) and maintained a price target of $27.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 1:22 pm

OPCH

Barrington Research analyst Michael Petusky has maintained an 'Outperform' rating on Option Care Health (NASDAQ:OPCH) and raised the price target from $34 to $41.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 1:20 pm

IMAX

Barrington Research analyst James Goss has reiterated his 'Outperform' rating on Imax (NYSE:IMAX), maintaining a $24 price target.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 1:19 pm

KOP

Barrington Research analyst Gary Prestopino has reiterated an 'Outperform' rating on Koppers Holdings (NYSE:KOP) and maintained a $40 price target.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 1:18 pm

MRSN

Citigroup analyst Ashik Kurian has downgraded Mersana Therapeutics from Buy to Neutral and lowered the price target from $10 to $1.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 1:18 pm

KAI

Barrington Research analyst Gary Prestopino has reiterated an 'Outperform' rating on Kadant (NYSE:KAI) and maintained a price target of $243.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 1:17 pm

DORM

Barrington Research analyst Gary Prestopino has reiterated an Outperform rating on Dorman Products (NASDAQ:DORM) and maintained a price target of $127.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 1:16 pm

DHX

Barrington Research analyst Gary Prestopino has reiterated an Outperform rating on DHI Group (NYSE:DHX) and maintained a $10 price target.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 1:15 pm